Trial Profile
Phase I Study of PD-L1 Inhibition With Avelumab and Laser Interstitial Thermal Therapy in Patients With Recurrent Glioblastoma
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Jan 2022
Price :
$35
*
At a glance
- Drugs Avelumab (Primary)
- Indications Glioblastoma
- Focus Adverse reactions; Therapeutic Use
- 13 Dec 2021 Status changed from recruiting to completed.
- 01 Sep 2020 Planned End Date changed from 1 Feb 2021 to 1 Sep 2021.
- 01 Sep 2020 Planned primary completion date changed from 1 Sep 2020 to 1 Sep 2021.